Is there a role for TNF-alpha antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique

Distler J. H. W., Jordan S., Airo P., Alegre-Sancho J. J., Allanore Y., Gurman A. B., ...More

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.29, no.2, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 2
  • Publication Date: 2011
  • Journal Name: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: scleroderma, TNF-alpha, fibrosis, NECROSIS-FACTOR-ALPHA, RANDOMIZED CONTROLLED-TRIALS, EULAR SCLERODERMA TRIAL, SYSTEMIC-SCLEROSIS, EOSINOPHILIC FASCIITIS, RHEUMATOID-ARTHRITIS, FIBROSING ALVEOLITIS, FATAL EXACERBATION, JOINT INVOLVEMENT, DOUBLE-BLIND
  • Marmara University Affiliated: No

Abstract

Objective: To obtain experiences and expert opinion on treatment of SSc patients with TNF-alpha antagonists.